PRAC meeting highlights 09 - 12 February 2026

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the February meeting are now available on the EMA website